focus -WSS

focus

author：leisure time 2025-10-01 17:06:15 - browse：74846

Senator Ron Wyden (D-OR) speaks with reporters in the Senate subway at the U.S. Capitol — Sen. Ron Wyden (D-Ore.) Drew Angerer/Getty Images

Senate Finance Committee members from both parties took aim Wednesday at insurance brokers that sell plans for large Medicare Advantage insurers.

Older adults at times have more than 100 plan options, and brokers help them choose the right one. But brokers can be incentivized by large insurance companies to aggressively sell plans that are a poor fit for the Medicare beneficiaries they’re supposed to help. Brokers also sometimes collect private information that they sell to multiple insurance companies. Those brokers tend to have a national scope, just like the large insurers they represent, compared to the independent, local brokers.

“They are big private marketing companies in the middle between seniors and their coverage,” Chairman Ron Wyden (D-Ore.) said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： European regulators consider appeal over Amylyx ALS drug

WSS

How to pay for weight loss drugs and save Medicare

How clinical AI models' predictive power can degrade over time

What the Wegovy shortage looks like for doctors — and for patients

What's changing in Medicare's open enrollment this year?

Takeda, Janssen join wearable maker to measure scratching

Diagnostic tests are hitting their mathematical limits

focus

focus

hotspot

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

What the Wegovy shortage looks like for doctors — and for patients

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How to pay for weight loss drugs and save Medicare

Hollywood unions extend contract negotiations for actors

European regulators consider appeal over Amylyx ALS drug

Sports medicine is finally prioritizing gender equality

As biotech industry slumps, bioscience job market is upside down

Peter Hotez and the public health issue of online harassment

STAT Readout: Today's biotech news includes Sana and Amylyx

explore

A revolution in caring for preterm infants

Wellcome Trust names Røttingen as its new CEO

Flagship Pioneering launches a new biotech in two countries

Massive project maps cells in human brain in unprecedented detail

How clinical AI models' predictive power can degrade over time

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

hotspot

explore

focus

hotspot